Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | CNR1 | P21554 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | ADH1B | P00325 | 1/20 | 0.36 |
| ▸ | ADH1C | P00326 | 1/20 | 0.36 |
| ▸ | ADH1A | P07327 | 1/20 | 0.36 |
| ▸ | ADH7 | P40394 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL197247 | 0.97 | LMNA (0.46) | LMNACNR1ADRA1ATDP1KDM4E | |
| Hydrochloric Acid SCHEMBL22575418 | 0.97 | ABCC3 (0.50) | LMNACNR1ADRA1ATDP1KDM4E | |
| Hydrazine SCHEMBL28481730 | 0.95 | LMNA (0.44) | LMNACNR1ADRA1ATDP1KDM4E | |
| SCHEMBL7775237 | 0.92 | TSHR (0.48) | LMNACNR1ADRA1ATDP1KDM4E | |
| SCHEMBL25132260 | 0.89 | EPHX1 (0.48) | LMNACNR1ADRA1ATDP1KDM4E | |
| SCHEMBL1237101 | 0.89 | EPHX1 (0.48) | LMNACNR1ADRA1ATDP1KDM4E | |
| SCHEMBL7776968 | 0.89 | EPHX1 (0.48) | LMNACNR1ADRA1ATDP1KDM4E | |
| Hydrochloric Acid SCHEMBL22575318 | 0.89 | ABCC3 (0.48) | LMNACNR1ADRA1ATDP1KDM4E | |
| SCHEMBL20033727 | 0.89 | EPHX1 (0.48) | LMNACNR1ADRA1ATDP1KDM4E | |
| SCHEMBL10879682 | 0.89 | EPHX1 (0.48) | LMNACNR1ADRA1ATDP1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112777585-B | Two-dimensional composite material, preparation method and application thereof | 清华大学 | 2022-10-04 | — | — | CN | claimed |
| CN-104577008-B | Partition and electrochemical appliance including it | 三星SDI株式会社 | 2018-12-18 | — | — | CN | claimed |
| US-9722224-B2 | Coated separator and electrochemical device including the same | SAMSUNG SDI CO., LTD. (KR) | 2017-08-01 | — | — | US | claimed |
| CN-104577008-A | Battery separation layer comprising a quaternary ammonium fluorinated salt coating material | SAMSUNG SDI CO LTD | 2015-04-29 | — | — | CN | claimed |
| US-20150111087-A1 | COATED SEPARATOR AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2015-04-23 | — | — | US | claimed |
| EP-2863452-A1 | Battery separation layer comprising a quaternary ammonium fluorinated salt coating material | Samsung SDI Co., Ltd. (KR) | 2015-04-22 | — | — | EP | claimed |
| EP-4268824-A1 | IMIDAZO[2,1-F][1,2,4]TRIAZINE DERIVATIVES USEFUL AS A MEDICAMENT | Manros Therapeutics (FR) | 2023-11-01 | — | — | EP | disclosed |
| US-11771715-B2 | Circular RNA compositions and methods | ORNA THERAPEUTICS, INC. (US) | 2023-10-03 | — | — | US | disclosed |
| US-11766449-B2 | Circular RNA compositions and methods | ORNA THERAPEUTICS, INC. (US) | 2023-09-26 | — | — | US | disclosed |
| US-20230226096-A1 | CIRCULAR RNA COMPOSITIONS AND METHODS | ORNA THERAPEUTICS, INC. | 2023-07-20 | — | — | US | disclosed |
| US-11679120-B2 | Circular RNA compositions and methods | ORNA THERAPEUTICS, INC. (US) | 2023-06-20 | — | — | US | disclosed |
| CN-112777585-B | Two-dimensional composite material, preparation method and application thereof | 清华大学 | 2022-10-04 | — | — | CN | disclosed |
| CN-104577008-B | Partition and electrochemical appliance including it | 三星SDI株式会社 | 2018-12-18 | — | — | CN | disclosed |
| EP-1599167-B1 | BENZIMIDAZOLE AND IMIDAZOPYRIDINE DERIVATIVES HAVING AFFINITY FOR THE MELANOCORTIN RECEPTORS AND USE THEREOF AS A MEDICAMENT | SOD CONSEILS RECH APPLIC (FR) | 2007-10-03 | — | — | EP | disclosed |
| US-7163643-B2 | Driving electrolyte and electrolytic capacitor using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2007-01-16 | — | — | US | disclosed |
| CN-1577658-A | Driving electrolyte and electrolytic capacitor using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO LTD (JP) | 2005-02-09 | — | — | CN | disclosed |
| US-20040262566-A1 | Driving electrolyte and electrolytic capacitor using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 2004-12-30 | — | — | US | disclosed |
| EP-0838508-B1 | Aqueous ink composition for use in an ink-jet printer | SEIKO EPSON CORP (JP) | 2001-08-29 | — | — | EP | disclosed |
| US-5871572-A | COLORANT, WATER, A WATER-SOLUBLE ORGANIC SOLVENT, AND PECTIC ACID | SEIKO EPSON CORPORATION (JP) | 1999-02-16 | — | — | US | disclosed |
| EP-0838508-A2 | Aqueous ink composition for use in an ink-jet printer | SEIKO EPSON CORPORATION (JP) | 1998-04-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11771715-B2 | Circular RNA compositions and methods | RTCB, HNRNPA1, HNRNPAB | LMNA 918/4885CNR1 4579/4885ADRA1A 4812/4885 |
| US-20230226096-A1 | CIRCULAR RNA COMPOSITIONS AND METHODS | RTCB, HNRNPA1, HNRNPAB | LMNA 918/4885CNR1 4579/4885ADRA1A 4812/4885 |
| US-11679120-B2 | Circular RNA compositions and methods | RTCB, HNRNPA1, HNRNPAB | LMNA 918/4885CNR1 4579/4885ADRA1A 4812/4885 |
| US-11766449-B2 | Circular RNA compositions and methods | RTCB, RNGTT, HNRNPAB | LMNA 1053/4885CNR1 4492/4885ADRA1A 4793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.